Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: TEVA PHARMACEUTICALS USA, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2020-08-05 to 2021-08-04
Current total value of award: $969614
Description: MANUFACTURING SUPPORT SERVICES FOR ADENOVIRUS STUDIES